January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
News | Antiplatelet and Anticoagulation Therapies | January 19, 2018
January 19, 2018 — The U.S. Food and Drug Administration (FDA) announced that International Laboratories LLC is...
News | Cardiovascular Business | January 16, 2018
January 16, 2018 — American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be...
News | Antiplatelet and Anticoagulation Therapies | December 12, 2017
December 12, 2017 — Mayo Clinic researchers have shown a link between which type of...
News | Antiplatelet and Anticoagulation Therapies | November 16, 2017
November 16, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes...
News | Heart Failure | November 13, 2017
November 10, 2017 — Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop...
Photo courtesy of Siemens Healthineers
News | Antiplatelet and Anticoagulation Therapies | November 06, 2017
November 6, 2017 — The first trial to evaluate the safety of...
News | Antiplatelet and Anticoagulation Therapies | November 03, 2017
November 3, 2017 — A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests...
Image courtesy of OrbusNeich
News | Stents Drug Eluting | November 01, 2017
November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at...
News | Stents | October 27, 2017
October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved...
News | Stem Cell Therapies | October 24, 2017
October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate...
News | Pharmaceuticals | October 18, 2017
October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...
News | Pharmaceuticals | October 04, 2017
October 4, 2017 — MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated...
